IVERIC bio (ISEE) – PRNewswire
-
Astellas Completes Acquisition of Iveric Bio
-
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
-
DelSiTech and Iveric Bio Enter Exclusive Agreement for Development of Sustained Release Zimura®
-
IVERIC bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings: Continuous Positive Treatment Effect with Favorable Safety Profile in Geographic Atrophy Secondary to Age-
Back to ISEE Stock Lookup